89 related articles for article (PubMed ID: 2035658)
1. Extent of glomerular injury in active and resolving lupus nephritis: a theoretical analysis.
Myers BD; Chagnac A; Golbetz H; Newton L; Strober S; Sibley RK
Am J Physiol; 1991 May; 260(5 Pt 2):F717-27. PubMed ID: 2035658
[TBL] [Abstract][Full Text] [Related]
2. Outcome of the acute glomerular injury in proliferative lupus nephritis.
Chagnac A; Kiberd BA; Fariñas MC; Strober S; Sibley RK; Hoppe R; Myers BD
J Clin Invest; 1989 Sep; 84(3):922-30. PubMed ID: 2760219
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of proteinuria in immune glomerular injury.
Myers BD
Am J Nephrol; 1990; 10 Suppl 1():19-23. PubMed ID: 1701613
[TBL] [Abstract][Full Text] [Related]
4. Murine lupus nephritis. A structure-function study.
Kiberd BA
Lab Invest; 1991 Jul; 65(1):51-60. PubMed ID: 2072665
[TBL] [Abstract][Full Text] [Related]
5. Modeling of progressive glomerular injury in humans with lupus nephritis.
Buckheit JB; Olshen RA; Blouch K; Myers BD
Am J Physiol; 1997 Jul; 273(1 Pt 2):F158-69. PubMed ID: 9249604
[TBL] [Abstract][Full Text] [Related]
6. Glomerular capillary wall function in human lupus nephritis.
Friedman S; Strober S; Field EH; Silverman E; Myers BD
Am J Physiol; 1984 May; 246(5 Pt 2):F580-91. PubMed ID: 6720964
[TBL] [Abstract][Full Text] [Related]
7. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L; Ordi-Ros J; Balada E; Segarra-Medrano A; Majó-Masferrer J; Labrador-Horrillo M; Vilardell-Tarrés M
Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
[TBL] [Abstract][Full Text] [Related]
8. Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease.
Austin SM; Lieberman JS; Newton LD; Mejia M; Peters WA; Myers BD
J Am Soc Nephrol; 1993 Jan; 3(7):1358-70. PubMed ID: 8439648
[TBL] [Abstract][Full Text] [Related]
9. Extent and course of glomerular injury in human membranous glomerulopathy.
Guasch A; Sibley RK; Huie P; Myers BD
Am J Physiol; 1992 Dec; 263(6 Pt 2):F1034-43. PubMed ID: 1282782
[TBL] [Abstract][Full Text] [Related]
10. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis.
Guasch A; Hashimoto H; Sibley RK; Deen WM; Myers BD
Am J Physiol; 1991 May; 260(5 Pt 2):F728-37. PubMed ID: 1709791
[TBL] [Abstract][Full Text] [Related]
11. The functional and structural changes of the glomerulus throughout the course of murine lupus nephritis.
Kiberd BA
J Am Soc Nephrol; 1992 Oct; 3(4):930-9. PubMed ID: 1450369
[TBL] [Abstract][Full Text] [Related]
12. Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy.
Yoo CW; Kim MK; Lee HS
Nephrol Dial Transplant; 2000 Oct; 15(10):1604-8. PubMed ID: 11007829
[TBL] [Abstract][Full Text] [Related]
13. Diffuse proliferative crescentic lupus nephritis with normal renal function.
Gupta V; Sachdeva S; Khan AS; Haque SF
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):343-5. PubMed ID: 22382232
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
15. Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis.
Chen S; Tang Z; Zhang Y; Liu Z; Zhang H; Hu W; Liu Z
Am J Nephrol; 2013; 38(6):445-52. PubMed ID: 24247741
[TBL] [Abstract][Full Text] [Related]
16. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide.
Kiberd BA; Young ID
J Lab Clin Med; 1994 Oct; 124(4):496-506. PubMed ID: 7930875
[TBL] [Abstract][Full Text] [Related]
17. Silent lupus nephritis with fingerprint deposits.
Tojo A; Kimura K; Hirata Y; Matsuoka H; Sugimoto T
Intern Med; 1993 Apr; 32(4):323-6. PubMed ID: 8358125
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic correlations in lupus nephritis in Lima, Peru.
Hurtado A; Asato C; Escudero E; Stromquist CS; Urcia J; Hurtado ME; de La Cruz S; Wener MH; Zavala R; Johnson RJ
Nephron; 1999; 83(4):323-30. PubMed ID: 10575294
[TBL] [Abstract][Full Text] [Related]
19. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
Hill GS; Delahousse M; Nochy D; Thervet E; Vrtovsnik F; Rémy P; Glotz D; Bariéty J
Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458
[TBL] [Abstract][Full Text] [Related]
20. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
